Intuitive Surgical (NASDAQ: ISRG) reported Q2 EPS of $5.95, $0.16 better than the analyst estimate of $5.79. Revenue for the quarter came in at $756 million versus the consensus estimate of $723.8 million.

• Worldwide da Vinci procedures grew approximately 16% compared with the second quarter of 2016, driven primarily by growth in U.S. general surgery procedures and worldwide urologic procedures.
• The Company shipped 166 da Vinci Surgical Systems compared with 130 in the second quarter of 2016.
• The Company launched a new da Vinci model, the da Vinci X, which provides surgeons and hospitals with access to some of the most advanced robotic-assisted surgery technology at a lower price.
• Second quarter 2017 revenue of $756 million grew approximately 13% compared with $670 million for the second quarter of 2016.
• Second quarter 2017 GAAP net income was $222 million, or $5.77 per diluted share, compared with $185 million, or $4.71 per diluted share, for the second quarter of 2016.
• Second quarter 2017 non-GAAP* net income was $228 million, or $5.95 per diluted share, compared with $220 million, or $5.62 per diluted share, for the second quarter of 2016.

For earnings history and earnings-related data on Intuitive Surgical (ISRG) click here.